-The Economic Times Soaring vegetable prices pushed inflation higher in April, while fuel and manufactured product prices sustained their pressure posing a fresh policy challenge and announcing the return of price pressures in Asia's third-largest economy. Data released by the commerce & industry ministry on Monday showed the annual rate of inflation, based on monthly wholesale price index, stood at 7.23% for April, 2012, compared to 6.89% for the previous month and...

Veteran agricultural scientist and alumnus of Harvard and Berkeley Universities, Dr Peter Kenmore was in Mumbai for NABARD’s 30th anniversary lecture on ‘Future of Global Agriculture: Challenges and Opportunities for India.’ This United Nations Food & Agriculture Organization India representative spoke to Yogesh Pawar on the current scenario in agriculture. Some excerpts: There’s a lot of churn over GM technology in India. At a time when the country is grappling with...

Pawar’s Report Card The Negatives     Per capita availability of cereals and pulses has fallen in last eight years     No improvement in irrigation, 60% of agriculture still dependent on monsoons     Farmers growing cereals, sugarcane, oilseeds and pulses assured higher MSP, but majority don't benefit     Production up, but not productivity. Farmer suicides are on the rise.     Poor market advisory on exports being misused to buy cheaply from farmers and make profits overseas     Pawar...

-The Hindu Business Line The onus of granting approvals to medicines marketed in the country is on the regulator Drug Controller General of India (DCGI), say drug companies, adding that they have adhered to the law of the land. The drug-makers were responding to a Parliamentary panel report on health that severely indicted the drug regulatory authority, besides alleging that “invisible hands” of drug-makers were involved in getting favourable reports on medicines...

The debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...